Molecular and cell biology of TGF-β

Mineral and Electrolyte Metabolism

Volumn 24, Issue 2-3, 1998, Pages 111-119

  Roberts, Anita B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Isoforms; Latent form; Promoters; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

AUTOIMMUNE DISEASE; CARCINOGENESIS; CELL GROWTH; CYTOLOGY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROSIS; GROWTH INHIBITION; HEMATOPOIETIC CELL; MESENCHYME CELL; MOLECULAR BIOLOGY; PARASITOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CELL DIVISION; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GROWTH INHIBITORS; HEMATOPOIETIC STEM CELLS; HUMANS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031933224     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057358     Document Type: Review

References (69)

1. Roberts AB, Sporn MB: The transforming growth factors-β; in Sporn MB, Roberts AB (eds): Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors. Berlin, Springer, 1990 pp 419-472.
2. Kingsley DM: The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994;8:133-146.
3. McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387:83-90.
4. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 1993;8:1-9.
5. Romeo DS, Park K, Roberts AB, Sporn MB, Kim SJ: An element of the transforming growth factor-beta 1 5′-untranslated region represses translation and specifically binds a cytosolic factor. Mol Endocrinol 1993;7:759-766.
6. Roberts AB, Sporn MB: Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev 1992;32:91-98.
7. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB: Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 1990;10:1492-1497.
8. Birchenall-Roberts MC, Ruscetti FW, Kasper J, Lee HD, Friedman R, Geiser A, Sporn MB, Roberts AB, Kim SJ: Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex. Mol Cell Biol 1990; 10:4978-4983.
9. Yoo YD, Ueda H, Park K, Flanders KC, Lee YI, Jay G, Kim SJ: Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest 1996;97:388-395.
10. Michelson S, Alcami J, Kim SJ, Danielpour D, Bachelerie F, Picard L, Bessia C, Paya C, Virelizier JL: Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J Virol 1994;68:5730-5737.
11. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ, Kim SJ: Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol 1994;8:595-602.
12. Lafyatis R, Lechleider R, Kim SJ, Jakowlew S, Roberts AB, Sporn MB: Structural and functional characterization of the transforming growth factor beta 3 promoter: A cAMP-responsive element regulates basal and induced transcription. J Biol Chem 1990;265:19128-19136.
13. O'Reilly MA, Geiser AG, Kim SJ, Bruggeman LA, Luu AX, Roberts AB, Sporn MB: Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-beta 2 promoter. J Biol Chem 1992;267:19938-19943.
14. Lafyatis R, Denhez F, Williams T, Sporn M, Roberts A: Sequence specific protein binding to and activation of the TGF-beta 3 promoter through a repeated TCCC motif. Nucl Acids Res 1991;19:6419-6425.
15. Letterio JJ, Kulkarni AB: The transforming growth factor β1 -knockout mouse; in Durum S, Muegge K (eds): Cytokine Knockout Mice. Clifton, Humana Press, 1997, in press.
16. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, Doetschman T: Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 1995;11:409-414.
17. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J: Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995;11:415-421.
18. Yang NN, Venugopalan M, Hardikar S, Glasebrook A: Identification of an estrogen response element activated by metabolites of 17 beta-estradiol and raloxifene. Science 1996;273: 1222-1225.
19. Salbert G, Fanjul A, Piedrafita FJ, Lu XP, Kim SJ, Tran P, Pfahl M: Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor beta 1 promoter by antagonizing AP-1 activity. Mol Endocrinol 1993;7:1347-1356.
20. Roberts AB, Sporn MB: Mechanistic interrelationships between two superfamilies: The steroid/retinoid receptors and transforming growth factor-β. Cancer Surv 1992;14:205-219.
21. Datto MB, Yu Y, Wang XF: Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 1995;270:28623-28628.
22. INK4B through an Sp1 concensus site. J Biol Chem 1995;270:26750-26753.
23. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B: A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell 1988;52: 405-414.
24. Hautmann MB, Madsen CS, Owens GK: A transforming growth factor β(TGF-β) control element drives TGF-β-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements. J Biol Chem 1997;272:10948-10956.
25. Kerr LD, Miller DB, Matrisian LM: TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 1990;61:267-278.
26. Matrisian LM, Ganser GL, Kerr LD, Pelton RW, Wood LD: Negative regulation of gene expression by TGF-beta. Mol Reprod Dev 1992;32:111-120.
27. Darnell JE Jr: The JAK-STAT pathway: summary of initial studies and recent advances. Rec Prog Horm Res 1996;51:391-403.
28. Chen X, Rubock MJ, Whitman M: A transcriptional partner for MAD proteins in TGF-beta signalling. Nature 1996;383:691-696.
29. Flaumenhaft R, Kojima S, Abe M, Rifkin DB: Activation of latent transforming growth factor beta. Adv Pharmacol 1993;24:51-76.
30. Barcellos-Hoff MH: Latency and activation in the control of TGF-β. J Mammary Gland Biol Neoplasia 1996;1:351-361.
31. Blanchette F, Day R, Dong W, Laprise MH, Dubois CM: TGFbeta1 regulates gene expression of its own converting enzyme furin. J Clin Invest 1997;99:1974-1983.
32. Lopez AR, Cook J, Deininger PL, Derynck R: Dominant negative mutants of transforming growth factor-beta 1 inhibit the secretion of different transforming growth factor-beta isoforms. Mol Cell Biol 1992;12:1674-1679.
33. Böttinger EP, Factor VM, Tsang ML, Weatherbee JA, Kopp JB, Qian SW, Wakefield LM, Roberts AB, Thorgeirsson SS, Sporn MB: The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci USA 1996; 93:5877-5882.
34. Taipale J, Miyazono K, Heldin CH, Keski-Oja J: Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 1994;124:171-181.
35. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC: Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1995;1: 932-937.
36. Nunes I, Shapiro RL, Rifkin DB: Characterization of latent TGF-beta activation by murine peritoneal macrophages. J Immunol 1995; 155: 1450-1459.
37. Khalil N, Corne S, Whitman C, Yacyshyn H: Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 1996;15:252-259.
38. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC: Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature 1994;370:460-462.
39. Carmeliet P, Bouche A, De Clercq C, Janssen S, Pollefeyt S, Wyns S, Mulligan RC, Collen D: Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-I genes in mice. Ann NY Acad Sci 1995;748:367-381.
40. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy-Ullrich JE: Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin I. J Biol Chem 1995;270:7304-7310.
41. Stach RM, Rowley DA: A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med 1993;178:841-852.
42. Rowley DA, Becken ET, Stach RM: Autoantibodies produced spontaneously by young lpr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses. J Exp Med 1995;181:1875-1880.
43. Caver TE, O'Sullivan FX, Gold LI, Gresham HD: Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice: IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection. J Clin Invest 1996;98:2496-2506.
44. LaMarre J, Hayes MA, Wollenberg GK, Hussaini I, Hall SW, Gonias SL: An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice. J Clin Invest 1991;87: 39-44.
45. Philip A, O'Connor-McCourt MD: Interaction of transforming growth factor-beta 1 with alpha 2-macroglobulin. Role in transforming growth factor-beta 1 clearance. J Biol Chem 1991;266: 22290-22296.
46. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996;2: 418-423.
47. Böttinger EP, Jakubczak JL, Roberts ISD, Mumy M, Hemmati P, Bagnall K, Merlino G, Wakefield LM: Expression of a dominant-negative mutant TGF-β type II receptor in transgenic mice reveals essential roles for TGF-β in regulation of growth and differentiation in the exocrine pancreas. EMBO J 1997;16:2621-2633.
48. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB: Maternal rescue of transforming growth factor-beta 1 null mice. Science 1994;264:1936-1938.
49. Wakefield LM, Letterio JJ, Chen T, Danielpour D, Allison RS, Pai LH, Denicoff AM, Noone MH, Cowan KH, O'Shaughnessy JA, Sporn MB: Transforming growth factor-β1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Can Res 1995;1:129-136.
50. Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB: Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 1990;86:1976-1984.
51. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Böttinger EP, Klotman PE, Thorgeirsson SS: Transgenic mice with increased plasma levels of TGF beta 1 develop progressive renal disease. Lab Invest 1996;74:991-1003.
52. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL: Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993;328:1592-1598.
53. Ivanovic V, Melman A, Davis-Joseph B, Ge-liebter J: Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer. Nature Med 1995;1:282-284.
54. Lowrance JH, O'Sullivan FX, Caver TE, Waegell W, Gresham HD: Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J Exp Med 1994; 180:1693-1703.
55. Zhu L, Herrera GA, Murphy-Ullrich JE, Huang ZQ, Sanders PW: Pathogenesis of glomerulosclerosis in light chain deposition disease: Role for transforming growth factor-beta. Am J Pathol 1995;147:375-385.
56. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A: The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1995;1:74-79.
57. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J: Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8: 345-351.
58. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, Lopez LA, Langa C, Fabra A, Letarte M, Bernabeu C: Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 1996;133:1109-1121.
59. Attisano L, Wrana JL: Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev 1996;7:327-339.
60. Sporn MB, Roberts AB: Autocrine secretion - 10 years later. Ann Intern Med 1992;117:408-414.
61. Coffman RL, Lebman DA, Shrader B: Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989;170:1039-1044.
62. Wakefield LM, Letterio JJ, Geiser AG, Flanders KC, O'Shaughnessy J, Roberts AB, Sporn MB: Transforming growth factor-beta s in mammary tumorigenesis: Promoters or antipromoters? Prog Clin Biol Res 1995;391:133-148.
63. Letterio JJ, Roberts AB: TGF-β: a critical modulator of immune cell function. J Immunol Immunopathol 1997;in press.
64. Roberts, AB, Sporn, MB: Transforming growth factor-β; in Clark RAF (ed): The Molecular and Cellular Biology of Wound Repair, ed 2. New York, Plenum Press, 1996, pp 275-308.
65. Markowitz SD, Roberts AB: Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 1996;7: 93-102.
66. Buske C, Becker D, Feuring-Buske M, Hannig H, Wulf G, Schafer C, Hiddemann W, Wormann B: TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors. Leukemia 1997;11:386-392.
67. Takiya S, Tagaya T, Takahashi K, Kawashima H, Kamiya M, Fukuzawa Y, Kobayashi S, Fukatsu A, Katoh K, Kakumu S: Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases. J Clin Pathol 1995;48:1093-1097.
68. Hsing AY, Kadomatsu K, Bonham MJ, Danielpour D: Regulation of apoptosis induced by transforming growth factor-beta1 in nontumorigenic rat prostatic epithelial cell lines. Cancer Res 1996;56:5146-5149.
69. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-1292.